PMC:7402624 / 6927-8060
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T34 | 456-462 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T4 | 456-462 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
205 | 9-17 | Species | denotes | patients | Tax:9606 |
206 | 224-232 | Species | denotes | patients | Tax:9606 |
207 | 335-343 | Species | denotes | patients | Tax:9606 |
208 | 528-536 | Species | denotes | patients | Tax:9606 |
209 | 583-591 | Species | denotes | patients | Tax:9606 |
210 | 697-705 | Species | denotes | patients | Tax:9606 |
211 | 886-894 | Species | denotes | patients | Tax:9606 |
212 | 1002-1010 | Species | denotes | patients | Tax:9606 |
213 | 724-742 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
214 | 744-747 | Chemical | denotes | HCQ | MESH:D006886 |
215 | 759-767 | Chemical | denotes | steroids | MESH:D013256 |
216 | 782-792 | Chemical | denotes | remdesivir | MESH:C000606551 |
217 | 0-8 | Disease | denotes | COVID-19 | MESH:C000657245 |
218 | 75-77 | Disease | denotes | HD | MESH:D006816 |
219 | 215-223 | Disease | denotes | COVID-19 | MESH:C000657245 |
220 | 326-334 | Disease | denotes | COVID-19 | MESH:C000657245 |
221 | 448-470 | Disease | denotes | chronic kidney disease | MESH:D051436 |
222 | 494-508 | Disease | denotes | thromboembolic | MESH:D013923 |
223 | 626-632 | Disease | denotes | cancer | MESH:D009369 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T56 | 0-8 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T57 | 75-77 | Disease | denotes | HD | http://purl.obolibrary.org/obo/MONDO_0007739 |
T58 | 82-84 | Disease | denotes | RD | http://purl.obolibrary.org/obo/MONDO_0009973 |
T59 | 215-223 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T60 | 326-334 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T61 | 448-470 | Disease | denotes | chronic kidney disease | http://purl.obolibrary.org/obo/MONDO_0005300 |
T62 | 456-470 | Disease | denotes | kidney disease | http://purl.obolibrary.org/obo/MONDO_0001343|http://purl.obolibrary.org/obo/MONDO_0005240 |
T64 | 626-632 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T71 | 22-23 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T72 | 82-84 | http://purl.obolibrary.org/obo/CLO_0008770 | denotes | RD |
T73 | 100-102 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
T74 | 304-306 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T75 | 304-306 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T76 | 456-462 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T77 | 456-462 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T78 | 456-462 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
T79 | 475-477 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T80 | 483-484 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T81 | 516-517 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T82 | 538-540 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T83 | 611-612 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T84 | 636-637 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T85 | 686-688 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
T86 | 846-847 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T87 | 1091-1099 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T20 | 75-77 | Chemical | denotes | HD | http://purl.obolibrary.org/obo/CHEBI_73925 |
T21 | 82-84 | Chemical | denotes | RD | http://purl.obolibrary.org/obo/CHEBI_73812 |
T22 | 304-306 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T23 | 724-742 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T24 | 759-767 | Chemical | denotes | steroids | http://purl.obolibrary.org/obo/CHEBI_35341 |
T25 | 782-792 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T4 | 448-470 | Phenotype | denotes | chronic kidney disease | http://purl.obolibrary.org/obo/HP_0012622 |
T5 | 494-514 | Phenotype | denotes | thromboembolic event | http://purl.obolibrary.org/obo/HP_0001907 |
T6 | 626-632 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T47 | 0-210 | Sentence | denotes | COVID-19 patients had a median age of 60 and were significantly older than HD and RD (median age of 41 and 29 respectively), though the age distributions for all three cohorts overlapped (Fig. 1A and fig. S1A). |
T48 | 211-308 | Sentence | denotes | For COVID-19 patients, median BMI was 29 (range 16-78), and 68% were African American (table S2). |
T49 | 309-410 | Sentence | denotes | Comorbidities in COVID-19 patients were dominated by cardiovascular risk factors (83% of the cohort). |
T50 | 411-515 | Sentence | denotes | Nearly 20% of subjects suffered from chronic kidney disease and 18% had a previous thromboembolic event. |
T51 | 516-685 | Sentence | denotes | A subset of patients (18%) were immunosuppressed, and 7% and 6% of patients were known to have a diagnosis of cancer or a pre-existing pulmonary condition, respectively. |
T52 | 686-793 | Sentence | denotes | 45% of the patients were treated with hydroxychloroquine (HCQ), 31% with steroids, and 29% with remdesivir. |
T53 | 794-865 | Sentence | denotes | Eighteen individuals died in the hospital or within a 30 day follow-up. |
T54 | 866-980 | Sentence | denotes | The majority of the patients were symptomatic at diagnosis and were enrolled ~9 days after initiation of symptoms. |
T55 | 981-1133 | Sentence | denotes | Approximately 30% of patients required mechanical ventilation at presentation, with additional extracorporeal membrane oxygenation (ECMO) in four cases. |